Screening for hepatitis C among HIV positive patients at Mulago Hospital in Uganda

African Health Sciences

Volumn 9, Issue 3, 2009, Pages 143-146

  Walusansa, V ^a   Kagimu, M ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCITES; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; SCREENING; UGANDA;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MASS SCREENING; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; UGANDA; YOUNG ADULT;

EID: 77949624489     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sulkwoski MS, Thomas DL. Hepatitis C in the HIV infected person. Annals of Internal Medicine 2003; 138: 197-207.
2. Balestra E., Aquaro S, Perno C.F. HIV/HCV coinfection the magnitude of the problem. Journal of Biological Regulators and Homeostatic agents 2003; 17: 138-43.
3. Centers for Disease Control and Prevention. Recommendations for Prevention and Control of hepatitis C virus (HCV) infection and HCV related chronic disease. MMWR 1998; 47:1-40.
4. Benhamou Y, Bochet M, Di Martino V et.al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C co-infected patients. The Multivirc Group. Hepatology 1999 ; 30 : 1054-8.
5. Puoti M, Torti C, Ripamonti D et.al. HIV-HCV Coinfection Study Group. Severe hepatotoxicity during combination anti-retroviral treatment: Incidence, liver histology and outcome. J. Acquir. Immune Defic Syndrome. 2003; 32: 259-67.
6. Sulkowski M.S, Thomas D.L., Chaisson R.E, More R.D. Hepatotoxicity associated with antiretroviral therapy in adults infected with Human Immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000; 283:74-80
7. Koziel M.J. Peters M.G. Viral Hepatitis in HIV infection. New England Journal of Medicine 2007; 356:1445-54.
8. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV infected persons - 2002. Recommendation of the US Public Health Service and the Infectious Disease Society of America. MMWR Recomm Rep. 2002; 51: 1-52.
9. Hladik W, Kataaha P, Mermin J et.al. Prevalence and screening costs for hepatitis C virus among Ugandan blood donors. Tropical Medicine and International Health 2006: 11:951-954.
10. Madhava V., Burgess C, Drucker E. Epidemiology of chronic hepatitis C infection in sub-Saharan Africa. Lancet Infect Dis. 2002; 2:293-302.
11. Kish, Leslie. Survey Sampling. New York : John Wiley and sons , 1965.
12. Tamale B, Mugyenyi PN. Prevalence of hepatitis C virus in patients infected with human immune deficiency virus at Joint Clinical Research Centre in Uganda. Int. Conf. AIDS 2002 Jul 7-12; 14: abstract No. C 10968.
13. Jackson JB, Guay L, Goldfarb J, Olness K, Ndugwa C, Mmiro F et al. Hepatitis C antibody in HIV-1 infected Ugandan mothers. Lancet 1991; 337: 551.
14. Biggar RJ, Ortiz-conde BA, Bagni RK et al. Hepatitis C virus genotype 4 in Ugandan children and their mothers. Emerging infectious diseases. www.cdc.gov/eid. Vol. 12. No. 9 September 2006; 1440 - 43.
15. Okoth FA, Viral Hepatitis .East African medical Journal 1996: 73(5): 308-312
16. Aceti A. Taliani G, De Bac, Sebastian A. Anti-HCV false positivity in malaria. Lancet 1990; 336:1442-43.
17. Anurag Maheshwari, Stuart Ray, Paul Thuluvath. Acute hepatitis C. Lancet 2008; 372:321-32.
18. th Edition. Edinburgh. Churchill Livingstone 2006 page 968.
19. Karuru J.W, Lule GN, Joshi M, Anzala O. Prevalence of HCV and HCV/HIV co-infection among in-patients at Kenyata National hospital. East African Medical Journal. 2005:82(4): 170-172.